Key features and details
- Rabbit polyclonal to Amyloid Fibril
- Suitable for: WB, IP, ELISA, IHC-P, IHC-Fr, Dot blot, ICC/IF
- Reacts with: Human
- Isotype: IgG
Product nameAnti-Amyloid Fibril antibody
See all Amyloid Fibril primary antibodies
DescriptionRabbit polyclonal to Amyloid Fibril
Tested applicationsSuitable for: WB, IP, ELISA, IHC-P, IHC-Fr, Dot blot, ICC/IFmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
Fibrils prepared from Human Aß42 peptide.
Storage instructionsShipped at 4°C. Store at -20ºC.
Storage bufferPreservative: 0.09% Sodium azide
Constituents: 50% Glycerol, 49% PBS
Concentration information loading...
PurityProtein A purified
Our Abpromise guarantee covers the use of ab126468 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration. Predicted molecular weight: 14 kDa.|
|IP||Use at an assay dependent concentration.|
|ELISA||Use at an assay dependent concentration.|
|IHC-P||Use at an assay dependent concentration.|
|IHC-Fr||Use at an assay dependent concentration.|
|ICC/IF||Use at an assay dependent concentration.|
- AAA antibody
- ABETA antibody
- ABPP antibody
Immunohistochmeistry labelling Amyloid fibril using ab126468 in hippocampus (A) subiculum (B) and frontal cortex (C) in Alzheimer disease. A higher magnImmunofluorescentication photograph illustrates that Amyliod fibril positive deposits were dense and consisted of fine fibrillar material (D).
Immunohistochemical detection of Amyloid Fibril in Human AD brain using ab126468.
ab126468 has been referenced in 1 publication.
- Peters F et al. Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease. EMBO J 38:e102345 (2019). PubMed: 31701556